BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 6198511)

  • 1. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
    Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
    Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
    Yamamura H; Kohno S; Ohata K
    Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacological profile and initial clinical evaluation of tiacrilast (Ro 22-3747): a new antiallergic agent.
    Welton AF; Dunton AW; McGhee B
    Agents Actions; 1986 Jun; 18(3-4):313-7. PubMed ID: 2428219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K; Akagi M; Izushi K; Mio M
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ro 21-7634, a new antiallergic agent with potent oral activity.
    Salvador RA; Czyzewski LB; Baruth H; Hooper A; Medford A; Miller D; van Trabert T; Yaremko B; Welton AF
    Agents Actions; 1981 Jul; 11(4):339-44. PubMed ID: 7025596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
    Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
    Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic characterization of the antiallergic activity of SK&F 78729-A.
    Chakrin LW; Krell RD
    J Pharmacol Exp Ther; 1978 Dec; 207(3):756-66. PubMed ID: 83359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
    Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release.
    Fleisch JH; Haisch KD; Spaethe SM; Rinkema LE; Cullinan GJ; Schmidt MJ; Marshall WS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):681-9. PubMed ID: 6202867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies on the mechanism of action of a new antiallergic, Ro 21-7634.
    Welton AF; Hope WC; Crowley HJ; Salvador RA
    Agents Actions; 1981 Jul; 11(4):345-51. PubMed ID: 6169263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.
    Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.
    Koda A; Nagai H; Sato N; Nakatomi I; Nishiyori T; Mori H; Inagaki N
    J Pharmacol; 1984; 15(3):353-73. PubMed ID: 6208430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
    Spicer BA; Ross JW; Smith H
    Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).
    Evans DP; Thomson DS
    Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals.
    Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y
    Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.